West Pharmaceutical Services, Inc. · WST · Next earnings

West Pharmaceutical Services, Inc. reports Thursday, Oct 22, 2026

WST reports before market open with consensus EPS at $2.18 and revenue at $826.0M. Last quarter: West Pharmaceutical Q2 2026: EPS and Revenue Beat, Guidance Raised Again

Reports Before market open32 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.18 Calendar consensus
Consensus revenue $826.0M Calendar consensus
Report date Oct 22, 2026 Thursday, date estimated
Session Before market open 32 days away

Where WST left off: FY2026 Q2

Full report

West Pharmaceutical Q2 2026: EPS and Revenue Beat, Guidance Raised Again

EPS surprise +13.9% Reported $2.37 vs $2.08
Revenue surprise +3.8% Reported $872.3M vs $840.0M
Stock move -0.8% Event window
Subsequent drift -4.5% Up to 20 sessions

Full-year guidance was raised for the second consecutive quarter. Organic revenue growth guidance increased from 7-9% to 10-11%. Adjusted EPS guidance increased from $8.40-$8.75 to $8.85-$9.05. Capex outlook is stable. Management tone remained confident with a bullish score of 88, up from 85 in the prior quarter.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Residual fallout from the cyber incident affecting the West Vantage segment.
  • Potential inflationary pressure from oil and commodity price increases.
  • FX headwinds from a stronger dollar.
  • Regulatory changes related to Annex 1 compliance.
  • Uncertainty around GLP-1 market momentum in the second half.

Questions analysts left open

  • Sustainability of non-GLP-1 HVP component growth.
  • Margin expansion outlook amid inflation and pricing pressures.
  • Impact of the SmartDose divestiture on future revenue and margins.
  • Timing and magnitude of West Vantage recovery post-cyber incident.
  • Second-half GLP-1 demand assumptions.

Ask FN2 about WST next report

Transcript, numbers and history already loaded
What should I watch for in WST's next earnings report?How did WST guide last quarter, and is consensus above or below that?Give me the bull and bear case going into WST earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the WST recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent WST quarters

All WST earnings
-0.8%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q2

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.